Compound to Control Presbyopia Symptoms

NCT05006898 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Optall Vision